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Ubiquitin-dependent protein degradation is es-
sential for cells to survive many environmental
stresses. Thus, it may be necessary to buffer
ubiquitin and proteasome pools against fluctu-
ation. Proteasome levels are tightly regulated,
and proteasome deficiency stimulates a stress
response. Here we report a novel pathway of
cellular response to ubiquitin depletion. Unlike
proteasome stress, ubiquitin stress does not
upregulate proteasome abundance. Instead,
ubiquitin stress alters proteasome composi-
tion. The proteasome-associated deubiquiti-
nating enzyme Ubp6, which spares ubiquitin
from proteasomal degradation, is induced by
ubiquitin deficiency. This enhances loading of
proteasomes with Ubp6, thereby altering pro-
teasome function. A catalytically inactive mu-
tant of Ubp6 fails to recycle ubiquitin and also
inhibits proteasome function directly, thus in-
ducing both ubiquitin stress and proteasome
stress. These results show that homeostatic
control of the ubiquitin-proteasome pathway
can be achieved through signal-dependent,
subunit-specific regulation of the proteasome,
and indicate a dual role of Ubp6 in regulating
ubiquitin levels and proteasome function.
INTRODUCTION
Ubiquitin is a highly conserved, 76 residue protein which
can be conjugated posttranslationally to other proteins
via an isopeptide linkage between glycine-76 of ubiquitin
and, most typically, the 3-amino group of a lysine within
the target protein. Ubiquitin itself contains seven lysines,
allowing the formation of ubiquitin-ubiquitin polymers.
Posttranslational modification by ubiquitin is utilized in a
number of cellular pathways, but the role of ubiquitin in se-
lective, intracellular protein degradation remains its best-
understood function. In this pathway, ubiquitin modifica-
tion serves as the recognitionmotif for a largemultisubunit
protease, known as the proteasome, which renders pro-
teins into small polypeptides.Initial identification of the ubiquitin genes revealed an
unusual mode of synthesis. In the budding yeast S. cere-
visiae, ubiquitin is encoded by four genes. Three of these
genes (UBI1-3) encode fusions of ribosomal proteins to
the C terminus of ubiquitin (Ozkaynak et al., 1987). The fi-
nal ubiquitin gene,UBI4, contains five head-to-tail repeats
of ubiquitin (Ozkaynak et al., 1987). In all cases, the gener-
ation of free ubiquitin requires the translation of a fusion
protein, an unusual event in eukaryotes, followed by post-
translational cleavage of ubiquitin at its C terminus, a reac-
tion carried out by one or more members of a family of
proteases known as deubiquitinating enzymes. Transcrip-
tional control of ubiquitin is highly regulated. Under normal
growth conditions, the bulk of cellular ubiquitin is provided
by UBI1-3. Stress conditions, such as heat shock, stimu-
late induction of UBI4 (Ozkaynak et al., 1987; Finley et al.,
1987). Transcription of ubiquitin genes is stimulated by
awide variety of cellular stresses in addition to heat shock,
and is controlled by a number of distinct transcriptional
pathways (Watt and Piper, 1997; Simon et al., 1999). The
complexity of regulation of ubiquitin biosynthesis likely
reflects the myriad roles of ubiquitin in cellular biology,
and the need for precise control over ubiquitin levels for
cellular homeostasis.
Ubiquitin is among the most physically stable proteins
known, and remains properly folded at temperatures up
to 85C and between a pH range of 1 and 13 (Lenkinski
et al., 1977). That ubiquitin displays a significant rate of
turnover is therefore intriguing. Early studies in mamma-
lian cells observed that under nutrient-rich conditions, the
bulk of ubiquitin degradation was nonlysosomal and ATP-
dependent (Haas and Bright, 1987; Hiroi and Rechsteiner,
1992). This degradation ismediated by the proteasome, as
more recent studies have demonstrated (Ryu et al., 2006).
Significant ubiquitin turnover has also been observed in
yeast, where the half-life of ubiquitin has been estimated
to be less than 2 hr (Hanna et al., 2003). The crucial role
of the proteasome in ubiquitin turnover is emphasized by
a yeast mutant lacking the UBP6 gene, which encodes a
proteasome-associated deubiquitinating enzyme. In the
absence of this protein, the half-life of ubiquitin is dramat-
ically reduced, and ubp6D cells rapidly become deficient
in steady-state ubiquitin levels, a feature which hypersen-
sitizes such cells to a wide variety of chemical and envi-
ronmental stresses (Leggett et al., 2002; Hanna et al.,
2003; Chernova et al., 2003). Ubp6 uses its catalytic activ-
ity to remove ubiquitin from proteasome substratesCell 129, 747–759, May 18, 2007 ª2007 Elsevier Inc. 747
(Hanna et al., 2006), and some fraction of this ubiquitin, de-
spite its physical stability, is apparently readily unfolded
by proteasomes and destroyed along with substrate in
the absence of Ubp6.
It has been assumed that the maintenance of cellular
ubiquitin levels is regulated primarily at the level of synthe-
sis. We demonstrate here a regulatory pathway that con-
trols cellular levels of ubiquitin by modulating processes
of deubiquitination and protein degradation. The cellular
abundance of Ubp6 is sensitive to the levels of cellular
ubiquitin: under conditions of ubiquitin depletion, Ubp6
abundance increases, and when ubiquitin levels are re-
stored by exogenous expression, Ubp6 levels return
to baseline. Ubiquitin-dependent upregulation of Ubp6
results in greater loading of proteasomes with Ubp6, pre-
sumably resulting in greater efficiency of ubiquitin recy-
cling at the proteasome. Intriguingly, a catalytically inac-
tive mutant of Ubp6 (ubp6-C118A) triggers the induction
of Ubp6, owing to cellular ubiquitin deficiency, but in con-
trast to the ubp6 null mutant, ubp6-C118A also displays
a general upregulation of total proteasome levels that is in-
dependent of ubiquitin levels, likely reflecting a previously
described noncatalytic function of Ubp6 in proteasome
inhibition (Hanna et al., 2006). Proteasome upregulation
in ubp6-C118A mutants is mediated by the transcription
factor Rpn4, and loss of proteasome compensation by
Rpn4 results in a severe growth defect. However, ubiqui-
tin-dependent induction of Ubp6 appears to be indepen-
dent of proteasome induction by Rpn4. These results
describe an unexpected pathway of cellular regulation,
provide evidence for the existence of a cellular ubiquitin
sensor, and indicate that despite the sequential and inter-
dependent nature of ubiquitination and proteasome-
mediated degradation in the ubiquitin-proteasome sys-
tem, the pathways controlling ubiquitin and proteasome
levels are largely independent.
RESULTS
Ubiquitin-Dependent Regulation of Ubp6
Protein Levels
We recently generated yeast CEN plasmids expressing
wild-type Ubp6 and a catalytically inactive mutant, Ubp6-
C118A, from the UBP6 promoter (Hanna et al., 2006).
Transformation of ubp6D cells with the wild-type plasmid
resulted in approximately wild-type expression levels of
the Ubp6 protein (Figure 1A). In contrast, ubp6D cells
harboring the Ubp6-C118A plasmid accumulated signifi-
cantly higher levels of the mutant protein (Figure 1A; for
quantitation, see Figure S1 in the Supplemental Data).
Levels of an unrelated protein, the translation initiation
factor eIF5A, were constant throughout, indicating the
specificity of these effects (Figure 1A).
Two related functions have been ascribed to the cata-
lytic activity of Ubp6: Ubp6 gradually removes ubiquitin
from proteasome-bound ubiquitin conjugates, and it pre-
vents or minimizes degradation of ubiquitin by the protea-
some. The degradation of ubiquitin by ubp6D protea-748 Cell 129, 747–759, May 18, 2007 ª2007 Elsevier Inc.somes presumably reflects that substrates not subject
to deubiquitination by Ubp6 can be unfolded and translo-
cated into the degradation-competent core particle of
the proteasome with at least some ubiquitin still attached,
resulting in degradation of both substrate and ubiquitin
components of the conjugate (Leggett et al., 2002; Cher-
nova et al., 2003; Hanna et al., 2006). Failure to regenerate
ubiquitin in the absence of Ubp6 results in deficient ubiq-
uitin content in ubp6D cells, giving rise to hypersensitivity
to a variety of chemical, environmental, and genetic
stresses (Chernova et al., 2003; Hanna et al., 2003). Be-
cause ubiquitin recycling by Ubp6 requires its catalytic
function, ubp6-C118A mutants largely recapitulate the
ubiquitin deficiency of the null mutant (Figure 1A). We
therefore hypothesized that accumulation of the Ubp6-
C118A protein might reflect a cellular response to ubiqui-
tin deficiency. This model predicts that a correction of
ubiquitin levels should restore Ubp6-C118A levels to nor-
mal, even without restoration of Ubp6’s catalytic activity.
Indeed, when ubiquitin levels were increased by express-
ing a synthetic ubiquitin gene in this strain, the difference
in abundance of Ubp6 and Ubp6-C118A levels was mini-
mized (Figure 1B). The plasmid-borne ubiquitin expres-
sion construct was chosen to correct ubiquitin levels
without dramatically overexpressing ubiquitin (see Exper-
imental Procedures), thus enhancing the likelihood of
identifying regulatory pathways that operate in a physio-
logical fluctuation range of ubiquitin.
Ubiquitin is conjugated posttranslationally to other pro-
teins, but is also known to bind a variety of proteins in
a noncovalent fashion. To determine whether conjugation
of ubiquitin was necessary for the downregulation of
Ubp6-C118A levels, we utilized a mutant of ubiquitin lack-
ing its final two glycine residues, which are required for
conjugation (hereafter referred to as ubiquitin-desGlyGly;
Arnason and Ellison, 1994). In contrast to results obtained
with wild-type ubiquitin, ubiquitin-desGlyGly was unable
to restore levels of Ubp6-C118A to those seen with wild-
type Ubp6 (Figure 1C). The inability of ubiquitin-desGlyGly
to influence Ubp6 levels could not be attributed to low
expression levels of the mutant ubiquitin. Indeed, when
ubiquitin-desGlyGly was expressed in ubp6D and ubp6-
C118A cells, the resulting total free ubiquitin content was
comparable to that of endogenous ubiquitin in a wild-type
cell (Figure 1C). These data suggest that ubiquitin conju-
gation is required for the pathway of ubiquitin-dependent
regulation of Ubp6, and the implications of this finding are
discussed in more detail below.
Endogenous Ubp6 Is Regulated by Ubiquitin Levels
We next sought evidence that the ubiquitin-dependent
regulation of Ubp6-C118A reflected a physiological cellu-
lar response. Were this the case, one would expect an in-
duction of wild-type, endogenous Ubp6 in response to
cellular ubiquitin deficiency that does not derive from
impaired Ubp6 function. To test this model, we employed
two independent ubiquitin-deficient yeastmutants: doa4D
and ubi1-3D (Swaminathan et al., 1999; Hanna et al., 2003;
Figure 1. Ubiquitin-Dependent Regula-
tion of Ubp6
(A) Cellular levels of Ubp6 and Ubp6-C118A
proteins, as determined by immunoblotting.
Middle panel, free ubiquitin; lower panel, eIF5A,
which serves as a loading control. Strains:
sJH152–sJH155.
(B) Cellular levels of Ubp6 and Ubp6-C118A af-
ter ubiquitin overexpression. Strains: sJH197–
sJH204.
(C) As in (B), except that the ubiquitin expres-
sion plasmid encoded a ubiquitin mutant (ubiq-
uitin-desGlyGly). Strains: sJH269–sJH276.Figure 2A). DOA4, like UBP6, encodes a deubiquitinating
enzyme. However, the ubiquitin deficiency in doa4D mu-
tants is suppressed by mutations in vacuolar proteases,
suggesting that the site of aberrant ubiquitin degradation
is the vacuole (Swaminathan et al., 1999), rather than the
proteasome, as seen for ubp6D (Hanna et al., 2003; Cher-
nova et al., 2003). The ubi1-3D mutant lacks three of the
four ubiquitin genes, but the ribosomal portions of these
fusion proteins are supplied on plasmids, as they are
essential for viability (see Table S1 in the Supplemental
Data). Upon examination of the doa4D and ubi1-3D
mutants, we observed increased levels of endogenous
Ubp6 protein (Figure 2A).
To confirm that increased Ubp6 levels in the ubp6-
C118A, doa4D, and ubi1-3Dmutants was due specifically
to the ubiquitin deficiency common to these mutants, and
not to some unappreciated common characteristic of the
three strains, we employed a yeast mutant in which all en-
dogenous ubiquitin coding elements have been removed
and replaced with a single galactose-inducible ubiquitin
gene. This strain allows for precise shut-off of ubiquitin
synthesis by switching the culture from a galactose-con-
taining medium to one containing glucose. As described
previously, cellular ubiquitin levels are rapidly depleted in
this strain upon cessation of ubiquitin synthesis, reflecting
ubiquitin turnover (Hanna et al., 2003; Figure 2B). In con-trast, as ubiquitin levels declined over the course of the
experiment, Ubp6 levels rose (Figure 2B). Again, levels
of an unrelated control protein, eIF5A, showed no corre-
sponding increase, indicating the specificity of the Ubp6
response. Together, the data of Figure 1 and Figure 2
indicate a robust cellular pathway for regulating Ubp6
that appears to respond precisely and specifically to the
amount of ubiquitin in the cell. Ubiquitin deficiency,
whether it arises through defects in biosynthesis or
through aberrant degradation by either the proteasome
or the vacuole, appears to be a sufficient signal for upre-
gulation of Ubp6.
A third deubiquitinating enzyme, Ubp14, was of interest
because of its known role in ubiquitin homeostasis. In con-
trast to ubp6D and doa4D mutants, ubp14D mutants are
not significantly deficient in either free or total ubiquitin;
rather, ubp14Dmutants accumulate unanchored polyubi-
quitin species (Amerik et al., 1997; see also Figure S2). We
examined Ubp6 levels in whole-cell extracts of these mu-
tants, and we were unable to detect significant induction
of the Ubp6 protein (Figure S2).
In addition to ubp6D, other yeast mutants, including
ufd3D and as described above doa4D, are known to be
deficient in ubiquitin (Swaminathan et al., 1999; Johnson
et al., 1995). We therefore sought to determine whether
Doa4 or Ufd3 might be subject to a similar pathway ofCell 129, 747–759, May 18, 2007 ª2007 Elsevier Inc. 749
Figure 2. Endogenous Ubp6 Is Regu-
lated by Ubiquitin Levels
(A) Cellular levels of endogenous Ubp6 in the
ubiquitin-deficient mutants doa4D and ubi1-3D.
Middle panel, free ubiquitin; lower panel,
eIF5A, which serves as a loading control.
(B) Cellular levels of endogenous Ubp6 after
cessation of ubiquitin synthesis.
(C) Cellular levels of TAP-Doa4 in response to
ubiquitin deficiency conferred by deletion of
UBP6. TAP-tagged constructs were detected
by immunoblotting, using a colorimetric assay
involving horseradish peroxidase and anti-
bodies to peroxidase.
(D) Schematic of Ubp6 expression constructs
used in (E).
(E) Cellular levels of free ubiquitin are affected
by reduction in Ubp6 levels. Upper panel,
Ubp6; lower panel, eIF5A, which serves as
a loading control. Strains: sJH152–sJH155,
sJH285–sJH286.ubiquitin-dependent regulation. We utilized strains bear-
ing TAP-tagged versions of Doa4 and Ufd3, respectively,
and rendered these strains ubiquitin deficient by deletion
ofUBP6. However, wewere unable to detect ubiquitin-de-
pendent induction of either TAP-Doa4 (Figure 2C) or TAP-
Ufd3 (data not shown), indicating some degree of specific-
ity of the ubiquitin-dependent pathway of Ubp6 induction.
Modulation of Ubiquitin Levels by Changes
in Cellular Abundance of Ubp6
The preceding data demonstrate that Ubp6 levels respond
sensitively to cellular ubiquitin levels. Whereas previous
work has demonstrated that the presence or absence of
Ubp6 dramatically affects ubiquitin levels (Leggett et al.,
2002; Chernova et al., 2003), we also sought to determine
whether incremental changes in Ubp6 levels could in turn
affect cellular ubiquitin abundance. We artificially reduced750 Cell 129, 747–759, May 18, 2007 ª2007 Elsevier Inc.expression of Ubp6 by removing a large portion of its pro-
moter sequence (Figure 2D). Such promoter truncation
also abolished ubiquitin-dependent upregulation of Ubp6
(Figure 2E). When we examined ubiquitin levels in these
strains, we observed that reduction in Ubp6 levels was
matched with corresponding reduction in free and total
ubiquitin levels (Figure 2E, and data not shown).
Ubiquitin-Dependent Upregulation of Ubp6
Is Mediated via Control of Gene Expression
An increase in abundance of Ubp6 protein could be
achieved through either an increase in synthesis or a de-
crease in degradation. To address this point, we followed
UBP6 RNA in cells responding to ubiquitin depletion. We
utilized the doa4D and ubi1-3Dmutants from Figure 2 and
observed a significant increase in wild-type UBP6 RNA
levels in both of these mutants, as determined by northern
Figure 3. Ubiquitin-Dependent Induction
of Ubp6 Is Transcriptional
(A) Cellular levels of UBP6 RNA in the ubiquitin-
deficient mutants, doa4D and ubi1-3D, as
determined by northern blotting. Actin RNA
serves as a loading control.
(B) Cellular levels of UBP6 and UBP6-C118A
RNA. Strains: sJH152–sJH155.blotting (Figure 3A). Consistent with these findings, when
we employed the ubp6-C118A mutant, which is ubiqui-
tin-deficient by virtue of the loss of Ubp6 catalytic activity,
we observed increased ubp6-C118A RNA levels as com-
pared with either a wild-type strain or a ubp6D strain com-
plemented with the wild-type Ubp6 plasmid (Figure 3B; for
quantitation, see Figure S3). These data indicate that the
observed ubiquitin-dependent upregulation of Ubp6 pro-
tein is mediated, at least in part, at the RNA level.
We next sought to determine whether a decrease in the
rate of degradation of the Ubp6 protein could also contrib-
ute to an increase in Ubp6 levels. To this end, we devel-
oped a yeast strain in which the endogenous UBP6
promoter has been replaced by the GAL1 promoter. This
allows for precise shut-off of Ubp6 synthesis, analogous
to the ubiquitin shut-off described in the experiment of
Figure 2B. After cessation of Ubp6 synthesis, we were un-
able to observe a significant decrease in Ubp6 abundance
over a 3 hr time course, indicating that the Ubp6 protein
is relatively stable (data not shown). Additionally, studies
of the human ortholog of Ubp6, known as Usp14, did
not reveal significant turnover of that protein (Borodovsky
et al., 2001).
Upregulation of Ubp6 Increases Proteasomal
Ubp6 Content
It is thought that the major known functions of Ubp6 are
carried out at the proteasome because deletion of
Ubp6’s proteasome binding domain (known as the Ubl
domain) recapitulates the null phenotype in every context
studied to date (Leggett et al., 2002; Chernova et al., 2003;
Hanna et al., 2006). Furthermore, because Ubp6 is dis-
pensable for the overall structural integrity of the protea-
some, its abundance on the proteasome could in principle
be varied in response to cellular demands. We therefore
sought to determine whether increases in total cellular
Ubp6 levels resulted in corresponding increases in the
amount of Ubp6 on proteasomes. Proteasomes were af-
finity purified (Leggett et al., 2002) from the ubiquitin-defi-
cient doa4D mutant, and compared to those of wild-type
yeast. The overall electrophoretic profiles of the two pro-
teasome preparations were similar (Figure 4A). It is difficult
to visualize Ubp6 by standard Coomassie staining be-cause it comigrates electrophoretically with the protea-
some subunit Rpn3. However, when we examined the
abundance of Ubp6 in these preparations by immunoblot-
ting, we detected an increased amount of Ubp6 in protea-
somes from the doa4D strain (Figure 4B). This difference
was specific for Ubp6, as levels of a different proteasome
subunit, Rpn12, were comparable between preparations
(Figure 4B).
We next examined proteasomes purified from a strain
expressing Ubp6-C118A. When compared with protea-
somes from either a wild-type strain or a ubp6D strain
complemented with a wild-type Ubp6 plasmid, protea-
somes from the ubp6-C118A mutant displayed a greater
amount of Ubp6 protein (Figure 4C; for quantitation, see
Figure S4). Again, this result was specific for Ubp6, as
other proteasome subunits, such as Rpn12, were not sim-
ilarly affected (Figure 4C). In the case of Ubp6-C118A, the
increase in Ubp6 association with the proteasome ap-
peared to be greater than that associated with protea-
somes from the doa4D strain. The reason for this differ-
ence remains unclear. Because the Ubp6-C118A protein
is devoid of catalytic activity, its increased accumulation
on proteasomes might reflect a futile and thus more per-
sistent cellular response to restore ubiquitin levels.
The data of Figures 4B and 4C indicate that protea-
somes from wild-type cells are not saturated with Ubp6.
Consistent with this model, when matrix-immobilized pu-
rified proteasomes from wild-type cells were challenged
with an excess of purified, bacterially produced Ubp6,
levels of proteasome-bound Ubp6 increased significantly,
with the increase comparable to that seen in Figure 4C
(data not shown). Whether the extent of proteasome load-
ing by Ubp6 is controlled by means other than UBP6 gene
expression remains to be evaluated.
Subunit-Specific Regulation of the Proteasome
In yeast, the synthesis of proteasome subunits, over 30 in
total, is thought to be coordinated through a specific
pathway of transcriptional control. All known proteasome
genes, including UBP6, contain a cis-acting upstream se-
quence of eight nucleotides known as the Proteasome-
Associated Control Element (PACE) (Mannhaupt et al.,
1999; Leggett et al., 2002). This regulatory element isCell 129, 747–759, May 18, 2007 ª2007 Elsevier Inc. 751
Figure 4. Induction of Ubp6 Increases
Proteasomal Ubp6 Content
(A) Coomassie blue staining of proteasomes
purified from wild-type and ubiquitin-deficient
doa4D strains.
(B) Proteasomes from (A) were analyzed by im-
munoblotting with antibodies against Ubp6
(upper panel) and proteasome subunit Rpn12
(lower panel).
(C) Proteasomal abundance of Ubp6 and
Ubp6-C118A. Proteasomes were purified and
analyzed by immunoblotting, as in (B). Strains:
sJH175–sJH178.
(D) Cellular levels of Ubp6 and proteasome
subunits Rpn5, Rpn8, and Rpn12 after cessa-
tion of ubiquitin synthesis. The Ubp6 panel is
taken from the experiment of Figure 2B.recognized by the zinc-finger transcriptional activator
Rpn4, which is itself short-lived by virtue of its rapid de-
struction by the proteasome (Xie and Varshavsky, 2001).
This system is thought to maintain an adequate level of
proteasome function via a negative feedback circuit. Un-
der conditions of adequate proteasome function, Rpn4
is rapidly degraded and thus present at a low level of
abundance. When proteasome function is compromised,
Rpn4 is stabilized and promotes proteasome synthesis
via transcription of proteasome genes. The increase in
proteasome function in turn leads to destruction of the
previously stabilized Rpn4 protein, thereby maintaining
proteasome homeostasis (Xie and Varshavsky, 2001).
The data from Figures 4B and 4C suggest a novel path-
way of proteasome regulation inasmuch as the stoichiom-
etry of Ubp6 on proteasomes changed relative to that of
other subunits. In contrast to the concerted regulation of
the proteasome as a single entity by Rpn4, it appears
that proteasome function can be modulated by specific
regulation of a single proteasome component. To sub-
stantiate this idea, we again utilized the technique of ubiq-
uitin shut-off to determine whether the observed changes
in cellular Ubp6 levels reflected a Ubp6-specific response
or whether they were simply a part of a larger program of
proteasome regulation. As shown in Figure 4D, the dra-
matic increase in Ubp6 levels that occurs as ubiquitin
levels decline is not accompanied by corresponding in-
creases in the cellular levels of three other proteasome
subunits, Rpn5, Rpn8, and Rpn12. Supporting this con-
clusion, the steady-state levels of proteasome compo-
nents other than Ubp6 also remained unchanged in ubiq-
uitin-deficient strains such as ubp6D (see Figure 5A,
below; Hanna et al., 2003; 2006) and doa4D (Figure S5).
An independent study of doa4D, furthermore, did not de-752 Cell 129, 747–759, May 18, 2007 ª2007 Elsevier Inc.tect significant induction of proteasome gene transcrip-
tion or stabilization of Rpn4 protein, two hallmarks of pro-
teasome stress (London et al., 2004). Therefore, the stress
associated with ubiquitin deficiency does not signal a
general proteasome stress response, but is addressed
through a novel pathway of proteasome subunit-specific
regulation.
Proteasome Stress in the ubp6-C118A Mutant
In the course of analyzing the ubp6-C118Amutant, we no-
ticed that the cellular levels of proteasome subunits such
as Rpn8 were elevated in comparison with those of a wild-
type strain (Figure 5A). We previously reported that Ubp6
possesses both a catalytic deubiquitinating activity and
a noncatalytic activity, the latter appearing to inhibit the
proteasome directly (Hanna et al., 2006). It seems likely
that increased proteasome levels in the ubp6-C118A mu-
tant reflect this noncatalytic inhibition of the proteasome,
especially as proteasome levels were not elevated in the
ubp6 null mutant (Figure 5A). Furthermore, whereas ubiq-
uitin supplementation could restore the abundance of the
Ubp6-C118A protein to wild-type levels, proteasome
levels remained elevated in the ubp6-C118Amutant, even
after complete ubiquitin restoration (Figure 5A). Thus, pro-
teasome induction in the ubp6-C118A mutant represents
a cellular response that is independent of both ubiquitin
levels and the catalytic function of Ubp6.
To further substantiate proteasome induction in the
ubp6-C118A mutant, we employed a more sensitive and
quantitative assay of cellular proteasome levels. suc-
LLVY-AMC is a fluorogenic peptide substrate of the pro-
teasome that can be degraded in a manner independent
of ubiquitin and the unfolding activities of the proteasome.
Thus, even under conditions in which the capacity of the
Figure 5. Proteasome Stress in the ubp6-C118A Mutant
(A) Cellular levels of proteasome subunit Rpn8 in wild-type, ubp6D, and ubp6-C118A strains (middle panel). Cellular levels of Ubp6 (top panel) are
shown for reference. eIF5A (lower panel) serves as a loading control. Strains: sJH197–sJH204.
(B) suc-LLVY-AMC hydrolysis by wild-type whole-cell extracts pretreated with DMSO (control) or the proteasome inhibitor clasto-lactacystin-b-
lactone (200 mM, dissolved in DMSO).
(C) suc-LLVY-AMC hydrolysis by whole-cell extracts (5 mg) from wild-type, ubp6D, and ubp6-C118A strains. The standard errors from an experiment
carried out in duplicate are shown. Strains: sJH152–sJH155.proteasome to degrade ubiquitinated proteins is compro-
mised, such as is likely the case for the ubp6-C118A mu-
tant, suc-LLVY-AMC can be used to assay proteasome
activity and, by extension, proteasome levels. Indeed,
suc-LLVY-AMC has been previously used in this way in
whole-cell extracts to demonstrate decreased protea-
some abundance in the rpn4D mutant (London et al.,
2004).
To be certain that the suc-LLVY-AMC assay faithfully
reported proteasome activity and not the activity of other
factors capable of cleaving this peptide, we first deter-
mined the fraction of suc-LLVY-AMC hydrolysis in a
whole-cell extract that could be attributed to protea-
somes. Addition of the proteasome inhibitor clasto-lacta-
cystin-b-lactone eliminated more than 95% of suc-LLVY-
AMC hydrolysis (Figure 5B), indicating that this assay can
faithfully report on proteasome activity. We next examined
the ubp6-C118A mutant directly. Wild-type and ubp6D
strains showed comparable activity against the peptide
substrate; in contrast, strains expressing Ubp6-C118A
displayed a strong increase in activity against suc-LLVY-
AMC (Figure 5C), consistent with the immunoblotting data
from Figure 5A. Additionally, neither Ubp6 (Hanna et al.,
2006) nor Ubp6-C118A (Figure S6) had any effect on
suc-LLVY-AMC hydrolysis activity by purified protea-
somes, indicating that increased suc-LLVY-AMC hydroly-sis in whole-cell extracts of ubp6-C118Amutants was un-
likely to be due to proteasome activation by Ubp6-C118A.
Thus, a noncatalytic function of Ubp6, most likely protea-
some inhibition, engenders a robust compensatory pro-
teasome stress response by the cell. In addition, these
results imply that the previously reported noncatalytic in-
hibition of the proteasome by Ubp6-C118A in vivo is com-
pensated and therefore likely to represent an underesti-
mate of the true proteasome inhibitory capacity of Ubp6
(Hanna et al., 2006).
Proteasome Compensation in the ubp6-C118A
Mutant Is Mediated by Rpn4
Given the known role of Rpn4 in proteasome regulation,
especially in response to stress, we examined how the
loss of Rpn4 would affect the ubp6-C118A mutant. When
ubp6-C118A was introduced into an rpn4Dmutant, a dra-
matic defect in growth was observed (Figure 6A). The
rpn4D ubp6D mutant alone showed no such growth de-
fect, indicating that the behavior of the rpn4D ubp6-C118A
mutant could not be attributed to ubiquitin deficiency or
loss of the enzymatic activity of Ubp6 (Figure 6A). Impor-
tantly, in anRPN4-positivegeneticbackground, theubp6D
and ubp6-C118A mutants showed comparable levels of
growth (Figure 6A), suggesting that the less marked phe-
notype of the ubp6-C118A mutant under nonstressCell 129, 747–759, May 18, 2007 ª2007 Elsevier Inc. 753
Figure 6. Rpn4-Mediated Cellular Compensation in the ubp6-C118A Mutant
(A) Primary transformants of the indicated strains were plated, grown for 2 days at 30C, and photographed. Strains: sJH261–sJH268.
(B) Liquid media growth curves for the strains shown in (A). (After 4–5 days of growth, rpn4D ubp6-C118A do form colonies, albeit smaller colonies
than any of the other seven strains shown.)
(C) suc-LLVY-AMC hydrolysis by whole-cell extracts (10 mg) prepared from the strains shown in (A) and (B). The standard errors from an experiment
carried out in duplicate are shown.
(D) Cellular levels of endogenous Ubp6 in an rpn4D doa4Dmutant. eIF5A serves as a loading control in the lower panel. Strains: SUB62, sJH213, 3716,
and sJH218.754 Cell 129, 747–759, May 18, 2007 ª2007 Elsevier Inc.
conditions is achieved only after significant cellular com-
pensation.
The rpn4D ubp6-C118A strain shown in Figure 6A, if
allowed to grow longer, will eventually form colonies, al-
though smaller ones than those of the other strains shown.
We collected such colonies and measured their growth
rates in liquid media. In an RPN4-positive background,
the ubp6D and ubp6-C118A mutants displayed similar
rates of growth. In contrast, in the rpn4D background,
the rate of growth of the ubp6-C118A mutant was signifi-
cantly slower than that of the ubp6D (Figure 6B), just as in
Figure 6A. This disparity in growth rates might represent
an underestimate of the difference, because it cannot be
excluded at present that upon propagation the rpn4D
ubp6-C118A transformants adapt to cellular stress im-
posed by those combined mutations through unknown
mechanisms.
It remained unclear whether the difference in growth
rates between the ubp6-C118A and rpn4D ubp6-C118A
mutants reflected true compensation byRpn4 for deficient
proteasome activity due to the presence of Ubp6-C118A
or whether a uniform reduction of proteasome levels by
deletion of RPN4 simply reduced proteasome activity in
the ubp6-C118Amutant below a critical threshold. To dis-
tinguish between these possibilities, we examined suc-
LLVY-AMC activities in these strains. In an RPN4-positive
background, we again noticed a strong increase in pep-
tide hydrolysis in the presence of Ubp6-C118A; in con-
trast, when RPN4 was deleted, not only did all strains
display a lower basal level of proteasome activity, but
the compensatory increase in suc-LLVY-AMC hydrolysis
in the ubp6-C118A mutant was almost completely abro-
gated (Figure 6C). Thus, Rpn4 is responsible for compen-
satory proteasome induction in response to Ubp6-C118A.
Our data describe two cellular pathways of regulation
within the ubiquitin-proteasome system, one controlling
ubiquitin levels and the other controlling proteasome
levels. We wished to determine whether these two path-
ways were controlled by the same factor or by different
factors. Rpn4 mediates proteasome synthesis in the
ubp6-C118A mutant. We therefore sought to determine
whether Rpn4 might also modulate ubiquitin-dependent
induction of Ubp6, especially as Ubp6 contains a putative
Rpn4 binding site in its promoter (Leggett et al., 2002). As
shown in Figure 2, ubiquitin deficiency arising from dele-
tion of the DOA4 gene is sufficient to elevate Ubp6 protein
levels. We therefore constructed an rpn4D doa4D double
mutant, which is significantly ubiquitin deficient compared
with the rpn4D mutant alone (data not shown). Overall
levels of Ubp6 were depressed in both the rpn4D and
rpn4D doa4D mutants, as expected, but considerable
compensatory induction of Ubp6 was observed in the
double mutant (Figure 6D). This result indicates that
Rpn4 is not necessary for the ubiquitin-dependent path-
way of Ubp6 regulation. Rather, it seems likely that the
two pathways of cellular regulation that control ubiquitin
and proteasome levels, respectively, are carried out by
distinct systems of gene regulation (see Figure 7).DISCUSSION
Ubiquitin-Dependent Regulation of Ubp6
Free ubiquitin levels are subject to major environmentally
induced fluctuations, even in wild-type cells (Rose and
Warms, 1987; Mimnaugh et al., 1997). Thus, the existence
of mechanisms that sense and correct transient inactiva-
tion of this pathway is a reasonable expectation. Perturba-
tions of ubiquitin levels could compromise cell function in
many respects because of the unusual scope of the ubiq-
uitin-dependent regulatory pathways. For example, ubiq-
uitination is critical to the control of processes such as cell
cycle regulation, transcription, cell surface receptor regu-
lation, protein quality control, apoptosis, DNA repair, and
protein sorting.
Ubiquitin deficiency is known to sensitize yeast cells to a
variety of chemical and environmental stresses, including
those associated with heat, protein misfolding, DNA dam-
age, exposure to heavy metals, inhibition of translation,
and starvation (Finley et al., 1987; Chernova et al., 2003;
Hanna et al., 2003). In higher eukaryotes, ubiquitin defi-
ciency is associated with disease in the ataxia and the
gracile axonal dystrophy (gad) mice (Wilson et al., 2002;
Saigoh et al., 1999). The former is caused by mutation in
murine Ubp6, known as Usp14, while the latter is due to
mutation in another deubiquitinating enzyme, Uch-L1,
which is also known to regulate ubiquitin levels (Osaka
et al., 2003).
The results presented here describe a novel pathway of
ubiquitin homeostasis that appears to modulate ubiquitin
levels not through regulation of ubiquitin synthesis, but
rather through regulation of ubiquitin degradation. The
proteasome-associated deubiquitinating enzyme Ubp6
functions to spare ubiquitin from degradation by the pro-
teasome, apparently by releasing ubiquitin from ubiquitin
conjugates, which are the major substrates of the protea-
some (Leggett et al., 2002). The absence of Ubp6 results in
Figure 7. Distinct Cellular Responses to Ubiquitin Stress and
Proteasome Stress
Homeostatic control of ubiquitin and proteasome levels, respectively,
by pathways which appear to be largely independent. Regulated pro-
teasome synthesis is mediated by the transcription factor Rpn4, which
is itself a substrate for degradation by the proteasome. Ubp6 spares
ubiquitin fromproteasomaldestruction, and is itself subject to regulated
gene expression by ubiquitin. This is an abbreviated representation of
the feedback loop,whichmust involve additional, so far unknown,com-
ponents. The mutant ubp6-C118A simultaneously induces ubiquitin
stress and proteasome stress, highlighting the key role of Ubp6 in reg-
ulating both ubiquitin levels and proteasome function.Cell 129, 747–759, May 18, 2007 ª2007 Elsevier Inc. 755
the rapid depletion of cellular ubiquitin (Leggett et al.,
2002). However, even in the presence of Ubp6, ubiquitin
displays a significant rate of degradation (Ryu et al.,
2006; Hanna et al., 2003), suggesting that the proteasome
is not fully efficient in recycling ubiquitin under steady-
state conditions. Furthermore, because Ubp6 is not an
integral subunit of the proteasome, and thus not required
for its structural integrity, the possibility exists that the
function of the proteasome could be altered simply by
altering the abundance of Ubp6. Considerable evidence
now supports this model: when ubiquitin levels decline, ei-
ther due to decreased synthesis or increased degradation,
the abundance of cellular Ubp6 rises. Conversely, ele-
vated levels of Ubp6 associated with ubiquitin deficiency
can be reversed simply by restoring ubiquitin. These re-
sults emphasize the physiological and regulatory signifi-
cance of ubiquitin degradation and the crucial role of ubiq-
uitin recycling in maintaining ubiquitin homeostasis.
The experiments presented here point to a new para-
digm in the regulation of the ubiquitin pathway: a ubiquitin
stress response. The physiologic relevance and effica-
ciousness of this stress response are suggested by the
ubiquitin-suppressible hypersensitivity of ubp6 null mu-
tants to stresses that are verydiverse in nature, and include
canavanine, anisomycin, cycloheximide, chlorampheni-
col, trichodermin, methotrexate, cadmium, 4NQO, and
methylmethanesulfonate (Chernova et al., 2003; Hanna
et al., 2003). Even in wild-type cells, we have found, sur-
prisingly, that sensitivity to many such treatments involves
ubiquitin limitation (Hanna et al., 2003, 2006; Chen and
Piper 1995). Thus, the ubiquitin stress response may rep-
resent a critical arm of the cellular stress-responsive regu-
latory system.
The induction of UBI4 transcription in response to ubiq-
uitin depletion is also known to occur (Swaminathan et al.,
1999; London et al., 2004). However, it remains unclear
whether or to what extent increased synthesis of new
ubiquitin plays a corrective role. According to existing
data, conditions that induce UBI4 also typically repress
the primary sources of ubiquitin under favorable condi-
tions, UBI1-3 (see, for example, Hanna et al., 2003; Finley
et al., 1987), and there is little basis to judge the net effect
of these opposing regulatory mechanisms. Some evi-
dence suggests that there may indeed be no net effect
(Swaminathan et al., 1999). Interestingly, UBI4 is also
known to be induced in proteasome hypomorphs in an
Rpn4-dependent manner (London et al., 2004). The signif-
icance of this response remains unclear, especially as the
overexpression of ubiquitin is actually toxic to at least
some proteasome hypomorphs (London et al., 2004).
Subunit-Specific Regulation of the Proteasome
The proteasome, as it was originally defined, consists of
a core group of essentially stoichiometric subunits that
is highly resistant to dissociation (see, for example, Glick-
man et al., 1998). The development of affinity purification
methods for the proteasome has recently allowed the
identification of a number of more loosely associated pro-756 Cell 129, 747–759, May 18, 2007 ª2007 Elsevier Inc.teasome components that are typically found at lower
abundance compared with the canonical proteasome
subunits (Verma et al., 2000; Leggett et al., 2002). In yeast,
proteasome synthesis is known to be regulated in a coor-
dinated manner, and the genes for every known protea-
some subunit, as well as a number of the loosely associ-
ated components such as Ubp6, contain a conserved
promoter sequence (PACE) that mediates the transcrip-
tional activation of such genes (Mannhaupt et al., 1999;
Leggett et al., 2002). Proteasome synthesis is induced in
response to a variety of stimuli that presumably either de-
crease proteasome function or increase demand for pro-
teasome function. Indeed, loss-of-function mutations in
proteasome subunits themselves can potently induce
the proteasome stress response (Ju et al., 2004; London
et al., 2004). Such responses also occur in metazoans, in-
cluding mammals, although the cis-acting elements and
transcriptional mediators remain unidentified (see, for ex-
ample, Meiners et al., 2003).
In the present work, we report that despite the wide-
spread requirement for ubiquitin in proteasome-mediated
degradation, ubiquitin stress does not engender an overt
proteasome stress response. Interestingly, these two
stress-response pathways must therefore be designed
so as to distinguish between protein degradation defects
arising from failure to ubiquitinate substrate and those
arising from failure to degrade the ubiquitinated from of
the substrate. Proteasome induction was not observed
in response to ubiquitin depletion arising either from a ces-
sation of ubiquitin synthesis or from accelerated ubiquitin
degradation in ubp6D and doa4D mutants. Instead, the
composition of the proteasomewas altered in amore sub-
tle manner through the relative accumulation of Ubp6 on
proteasomes.
Theproteasomehas traditionallybeenviewedasasingle
functional entity in yeast, and proteasome regulation was
thought to focus on control of its levels and not the nature
of its activity. The data presented here support an alternate
model in which proteasome function may be not only in-
creased or decreased, but altered in more sophisticated
ways to address variable cellular requirements. It seems
less likely that the core stoichiometric subunits of the pro-
teasomecould serve such regulatory rolesbecauseof their
requirement for overall proteasome structure and stability,
although the activity of such subunits might still be regu-
lated posttranslationally. In contrast, the reversibility of
binding and typically substoichiometric representation of
proteasome-associating factors make them ideal candi-
dates for subunit-specific modulation of the proteasome.
Ubp6 is clearly utilized by the cell to this end, but we sus-
pect that other proteasome-associating proteins might
similarly function as key mediators of proteasome regula-
tion, with their levels being modulated to address other
as of yet unappreciated cellular demands.
Evidence for a Ubiquitin Sensor
The precise regulation of Ubp6 in response to ubiquitin
levels, and the fact that increases in Ubp6 are achieved,
at least in part, via a program of UBP6 gene regulation,
provide strong evidence for the existence of a cellular
component capable of sensing ubiquitin levels. In princi-
ple, such a sensor could function either by binding ubiqui-
tin or through covalent conjugation to ubiquitin itself. The
data of Figure 1C suggest that ubiquitin sensing requires
ubiquitin conjugation. The sensor is likely to be conjugated
directly to ubiquitin or to bind a polyubiquitin structure. In
the case of direct conjugation, the role of ubiquitin in pro-
moting protein destruction could provide a straightforward
negative feedback loop responsive to ubiquitin levels.
However, an alternative scenario in which the sensor rec-
ognizes the C terminus of unconjugated ubiquitin cannot
be excluded.
The identification of the putative ubiquitin sensor, as
well other components of the transcriptional pathway reg-
ulating ubiquitin-dependent induction of Ubp6, represents
a challenge for the future. Until these factors are identified,
our understanding of the ubiquitin stress response will re-
main partial. In particular, defining the relevant cis-acting
element in the UBP6 promoter will allow testing of the
physiological effects of UBP6 induction in ubiquitin-defi-
cient cells and facilitate searches for the corresponding
transcriptional regulators.
Simultaneous Activation of Ubiquitin
and Proteasome Stress Responses by ubp6-C118A
We previously reported that Ubp6, in addition to its cata-
lytic deubiquitinating activity, possesses a noncatalytic
activity capable of delaying substrate degradation by
direct inhibition of the proteasome (Hanna et al., 2006).
However, the scope and generality of such noncatalytic
inhibition remained unclear.We now show that this nonca-
talytic inhibition, when divorced from Ubp6’s catalytic
activity in the ubp6-C118A mutant, has profound conse-
quences for the entire ubiquitin-proteasome pathway
in vivo. ubp6-C118A potently stimulates a proteasome
stress response, and proteasome levels in such cells
rise substantially. When the ability of cells to compensate
for such proteasome inhibition is abrogated by loss of the
proteasome stress response factor Rpn4, ubp6-C118A
mutants suffer a marked reduction in growth rates. To-
gether, these data indicate that the effect of noncatalytic
proteasome inhibition by Ubp6 is unlikely to be highly
restricted in scope.
The induction of proteasome subunits in the ubp6-
C118A mutant, as well as the reduction in its growth rate
when combined with an rpn4D mutant, are not observed
in the ubp6D mutant. These results are consistent with
our previous assignment of Ubp6 as a proteasome inhib-
itor, the complete absence of which accentuates protea-
some function (Hanna et al., 2006). More importantly,
these particular nonequivalencies between the ubp6-
C118A mutant and both the wild-type and ubp6D strains
suggest that proteasome stress observed in the ubp6-
C118Amutant derives from the uncoupling of noncatalytic
inhibition from catalytic function. This would imply that the
presence of distinct catalytic and noncatalytic functions inUbp6 is not fortuitous. Rather, it appears that the two ac-
tivities of Ubp6 are functionally related, and that noncata-
lytic inhibition of the proteasome may subserve Ubp6’s
catalytic function. When catalytic function is abrogated,
the proteasome is subject to persistent noncatalytic inhi-
bition, and may not be able to engage a new substrate
until either release from noncatalytic inhibition or dissoci-
ation of the stalled substrate from the proteasome. The
dissociative pathway could be promoted by substrate
deubiquitination, possibly representing a key role of
Ubp6’s catalytic activity.
Theworkpresentedheredescribes twopathwaysof cel-
lular regulation, which we have referred to as the ubiquitin
stress response and the proteasome stress response, re-
spectively (see Figure 7). The ubiquitin stress response
is distinct from the proteasome stress response; in partic-
ular, the principal mediator of the proteasome stress re-
sponse, Rpn4, does not appear to control the ubiquitin
stress response. Though such a two-fold stress regulation
in the ubiquitin-proteasome pathway has not been antici-
pated, it is perhaps a logical solution.When ubiquitin levels
are dangerously low, it would not be advantageous to in-
crease proteasome levels, as this would likely exacerbate
ubiquitin depletion. Moreover, it is intriguing that the deg-
radation of Rpn4 has the rare feature of having a strong
ubiquitin-independent component (Xie and Varshavsky,
2001); thus Rpn4 seems to respond rather specifically to
the state of the proteasome rather than ubiquitin levels,
even though ubiquitin levels might bemore subject to fluc-
tuationphysiologically (RoseandWarms, 1987;Mimnaugh
et al., 1997; Hanna et al., 2003). The ubp6-C118A mutant
may provide an exceptional case of regulation, where the
ubiquitin stress response and proteasome stress re-
sponseare triggered simultaneously (Figure 7). The joint in-
duction of these pathways reflects the key role of Ubp6 in
their regulation. It is possible that, at any given time, only
one or the other of the two pathways will be significantly
induced under physiologically relevant environmental
stresses.
EXPERIMENTAL PROCEDURES
Yeast Strains
See Table S1. Standard techniques were used for strain constructions
and transformations. Yeast were cultured at 30C. YPD medium con-
sisted of 1% yeast extract, 2% Bacto-peptone, and 2% dextrose.
YPRafGal consisted of 1% yeast extract, 2% Bacto-peptone, 2% raf-
finose, and 2% galactose. Synthetic medium consisted of 0.7% Difco
Yeast Nitrogen Base supplemented with amino acids, adenine, uracil,
and 2% dextrose. Yeast plasmids are described in Table S2. Ubiquitin
expression was carried out in the absence of copper induction. Under
these conditions, free ubiquitin levels are elevated by a factor of
approximately two in the wild-type (see, for example, Figure 1).
Preparation of Whole-Cell Extracts for Immunoblotting
Logarithmically growing cells were harvested and resuspended in 1X-
Laemmli loading buffer at a concentration of 23 107 cells/50 ml loading
buffer. Samples were immediately boiled and analyzed by SDS-PAGE
followed by immunoblotting. Wherever possible, blots were stripped
and reprobed to minimize error due to sample loading.Cell 129, 747–759, May 18, 2007 ª2007 Elsevier Inc. 757
For ubiquitin shut-off experiments utilizing the SUB328 strain, cells
growing logarithmically in YPRafGal were harvested, washed twice
in water, and resuspended in YPD. An equivalent number of cells
was collected at the indicated time points and processed as described
above.
Analysis of UBP6 RNA
Total RNA was prepared from logarithmically growing cells, separated
by agarose gel electrophoresis, and transferred to a Hybond-N+mem-
brane (Amersham Biosciences) using the Turboblotter System Kit
(Whatman Schleicher & Schuell). 32P-dUTP-labeled PCR fragments
(600 bp) from the UBP6 and ACT1 genes, respectively, were used
for blotting. For Ubp6 blots, 25 mg of RNA were analyzed; for actin
blots, 5 mg of RNA were analyzed.
Proteasome Purification
Proteasome purification was carried out as previously described
(Hanna et al., 2006; Leggett et al., 2002).
suc-LLVY-AMC Assays
Logarithmically growing cells were harvested and resuspended in
buffer (50 mM Tris-HCl [pH 8.0], 1 mM EDTA, 5 mM MgCl2, and
1 mM ATP). Cells were lysed by French press and clarified by centri-
fugation in an SS-34 rotor for 30 min at 16,0003 g. Extracts were nor-
malized by protein concentration and incubated with suc-LLVY-AMC
(100 mM) for 10 min at 30C. Reactions were stopped by the addition
of 1% SDS, and the extent of suc-LLVY-AMC hydrolysis was mea-
sured using a fluorimeter.
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.cell.com/cgi/content/full/129/4/747/DC1/.
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